Abstract
A series of oseltamivir analogues bearing an N-substituted guanidine unit were prepared and evaluated as inhibitors of neuraminidases from four strains of influenza. The two most potent analogues identified contain relatively small N-guanidine substituents (N-methyl and N-hydroxyl) and display enhanced inhibition with IC50 values in the low nanomolar range against neuraminidases from wild-type and oseltamivir-resistant strains. Potential advantages of including the N-hydroxyguanidine moiety in neuraminidase inhibitors are also discussed.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Drug Resistance, Viral / drug effects
-
Drug Resistance, Viral / genetics
-
Guanidines / chemistry*
-
Humans
-
Influenza A virus / drug effects*
-
Influenza, Human / drug therapy
-
Influenza, Human / virology
-
Models, Molecular
-
Molecular Structure
-
Mutation / genetics
-
Neuraminidase / antagonists & inhibitors*
-
Neuraminidase / genetics
-
Neuraminidase / metabolism
-
Oseltamivir / chemistry*
-
Oseltamivir / pharmacology*
-
Structure-Activity Relationship
Substances
-
Antiviral Agents
-
Guanidines
-
Oseltamivir
-
Neuraminidase